Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03742076 · ClinicalTrials.gov registry record · NA
Effect of Gum Arabic on Gastrointestinal Transit and Permeability
A NA study of Diverticulitis, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT03742076: Completed NA study of Diverticulitis, sponsored by Mayo Clinic.
NCT03742076 is a NA study of Diverticulitis that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants, below the 25,232-participant average among 8 other Diverticulitis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03742076, a NA study of Diverticulitis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to determine the effect of gum arabic on gut bacteria and GI function.
Primary Outcome
The scintigraphic method is used to measure colonic transit. An isotope is adsorbed on activated charcoal particles and delivered to the colon in a delayed release capsule. Anterior and posterior gamma images are taken hourly. The geometric center (GC) is the weighted average of counts in the different colonic regions. The scale ranges from 1 to 5; a high GC implies faster colonic transit, a GC of 1 implies all isotope is in the ascending colon, and a GC of 5 implies all isotope is in the stool.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT High-dose prebiotic
- DIETARY_SUPPLEMENT Low-dose prebiotic
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
What the finished NCT03742076 record still lists
NCT03742076 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 25,232-participant average among 8 other Diverticulitis trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Diverticulitis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03742076 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03742076 about?
NCT03742076 is a clinical study titled "Effect of Gum Arabic on Gastrointestinal Transit and Permeability". The study aims to determine the effect of gum arabic on gut bacteria and GI function.
What is the current status of trial NCT03742076?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2018-12-18. Estimated completion is 2021-03-01.
What conditions does trial NCT03742076 study?
This clinical trial studies the following conditions: Diverticulitis.
What interventions are being tested in trial NCT03742076?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), High-dose prebiotic (DIETARY_SUPPLEMENT), Low-dose prebiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03742076?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03742076 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diverticulitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03742076's enrollment target sits among peer trials
27 8th of 8 higher than 1 of 8 other Diverticulitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diverticulitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial
ACTIVE NOT RECRUITING · NA
-
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
ACTIVE NOT RECRUITING · NA
-
FMT in Uncomplicated Diverticulitis
ACTIVE NOT RECRUITING · Early Phase 1
-
Early Post-Op Recovery After Partial Large Bowel Resection
COMPLETED
-
Prevention of Recurrence of Diverticulitis
COMPLETED · Phase 3
-
General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI